Sponsored Content
Swiss Novartis Opens Fastest Cell Culture Facility in Tyrol
Novartis opened a state-of-the-art cell culture facility for the production of monoclonal antibodies in Schaftenau, Tyrol.
From left to right: Oskar Wolkenstein, Roland Gander, Cornelia Hagele, Martin Kocher, Kuntal Baveja and Max Kloger / Picture: © Novarits Österreich/Martin Vandory
The facility, named CC2Plus, is considered the fastest and most efficient cell culture facility in the Novartis network. With an investment of 250 million euros, this is a significant step towards strengthening the pharmaceutical company's production capacities.
"The new facility enables us to increase output by 170 percent," explained site manager Roland Gander. "It will enable…
or Log In
Fast News Search